On The Fly
|
Check out this evening's… ShowHide Related Items >><< - 01/17/23
- United Airlines ends 2022 with available liquidity of $18.2B
- 01/17/23
- United Airlines sees FY23 capacity up 'high teens' y/y
- 01/17/23
- United Airlines sees Q1 capacity up ~20% y/y
- 01/17/23
- United Airlines jumps 5% to $53.91 after Q4 results, FY23 guidance top estimates
- 01/03/23
- Progress Software to acquire MarkLogic for $355M
- 09/26/22
- Progress Software apponts YuFan Stephanie Wang to CLO
- 09/22/22
- Progress expands Microsoft collaboration to accelerate cloud migration in India
- 09/14/22
- Progress Software announces latest release of developer tools portfolio
- 01/17/23
- Nicolet Bankshares sees FY23 deposits reprice higher and loan volume softer
- 01/17/23
- Moderna jumps 7% to $203.21 after announcing data from mRNA-13 efficacy trial
- 01/17/23
- Moderna announces data from efficacy trial of mRNA-1345 targeting RSV
- 01/13/23
- FDA sees preliminary safety signal for older users of Pfizer bivalent vaccine
- 01/10/23
- Senator Sanders says Moderna COVID vaccine pricing shows 'unacceptable' greed
- 01/17/23
- Interactive Brokers reports Q4 customer accounts up 25% y/y to 2.09M
- 01/03/23
- Interactive Brokers reports December DARTs down 21% y/y
- 12/01/22
- Interactive Brokers reports November DARTs down 30% vs. last year
- 11/02/22
- Interactive Brokers chairman sells $3.2M in common stock
- 07/25/22
- Hancock Whitney CEO sells 26,473 common shares
- 01/17/23
- Arcimoto falls 25% afterhours to $4.59 after offering common stock
- 12/13/22
- Arcimoto announces development of driverless EVs for tourism rentals
- 12/05/22
- Arcimoto trading resumes
- 12/05/22
- Arcimoto trading halted, volatility trading pause
FULC Fulcrum Therapeutics - 01/04/23
- Fulcrum Therapeutics sees cash runway into late 2024
- 01/04/23
- Fulcrum Therapeutics provides business update, upcoming milestones
- 01/04/23
- Fulcrum Therapeutics CEO Bryan Stuart departs
- 11/07/22
- Fulcrum appoints new Chief Medical and new Chief Scientific officers
- 01/09/23 Citi
- Citi opens 'positive 30-day catalyst watch' on Interactive Brokers
- 12/19/22 Barclays
- Interactive Brokers price target lowered to $90 from $94 at Barclays
- 10/19/22 Barclays
- Interactive Brokers price target raised to $94 from $88 at Barclays
- 10/12/22 Citi
- Citi starts exchanges and brokers with CME, MarketAxess among top picks
- 01/12/23 Barclays
- United Airlines price target raised to $45 from $42 at Barclays
- 01/11/23 Jefferies
- Delta Air Lines price target raised to $45 from $40 at Jefferies
- 01/11/23 Barclays
- United Airlines price target raised to $45 from $42 at Barclays
- 12/16/22 Goldman Sachs
- United Airlines resumed with a Buy at Goldman Sachs
- 01/11/23 Deutsche Bank
- Moderna price target raised to $225 from $185 at Deutsche Bank
- 01/05/23 Morgan Stanley
- Morgan Stanley sees Moderna's phase 3 RSV vaccine data as catalyst-driven idea
- 12/20/22 Piper Sandler
- Moderna price target raised to $217 from $214 at Piper Sandler
- 12/19/22 Jefferies
- Moderna upgraded to Buy from Hold at Jefferies
- 09/29/22 Citi
- Progress Software price target lowered to $46 from $52 at Citi
- 09/09/22 Jefferies
- Progress Software initiated with a Hold at Jefferies
- 08/11/22 Guggenheim
- Progress Software initiated with a Buy at Guggenheim
- 06/29/22 Oppenheimer
- Progress Software price target lowered to $53 from $60 at Oppenheimer
- 08/16/22 DA Davidson
- Hancock Whitney price target raised to $60 from $56 at DA Davidson
- 07/11/22 Jefferies
- Hancock Whitney price target lowered to $55 from $60 at Jefferies
- 06/15/22 Truist
- Hancock Whitney price target lowered to $58 from $63 at Truist
- 03/28/22 Truist
- Hancock Whitney price target lowered to $65 from $70 at Truist
- 12/01/22 Alliance Global Partners
- Arcimoto price target raised to $11 from $7 at Alliance Global Partners
- 09/06/22 Dawson James
- Arcimoto downgraded to Sell from Neutral at Dawson James
- 06/21/22 Dawson James
- Arcimoto producing more cars but still needs cash, says Dawson James
- 06/02/22 Alliance Global Partners
- Arcimoto price target lowered to $11 from $18 at Alliance Global Partners
- 03/02/22 Lake Street
- Big 5 Sporting price target lowered to $28 from $31 at Lake Street
- 01/28/22 Sidoti
- Big 5 Sporting initiated with a Buy at Sidoti
FULC Fulcrum Therapeutics - 01/04/23 Piper Sandler
- Fulcrum reports 'encouraging' Phase 1b data for FTX-6058, says Piper Sandler
- 01/04/23 Oppenheimer
- Fulcrum 'may have just gotten more controversial,' says Oppenheimer
- 11/15/22 Goldman Sachs
- Fulcrum Therapeutics initiated with a Buy at Goldman Sachs
- 11/08/22 Piper Sandler
- Fulcrum Therapeutics price target lowered to $18 from $42 at Piper Sandler
- 01/17/23
- United Airlines sees FY23 adjusted EPS $10.00-$12.00, consensus $6.54
- 01/17/23
- United Airlines sees Q1 adjusted EPS 50c-$1.00, consensus 25c
- 01/17/23
- United Airlines reports Q4 adjusted EPS $2.46, consensus $2.10
- 01/17/23
- Notable companies reporting after market close
- 01/17/23
- Progress Software sees FY23 EPS $4.09 - $4.17 , consensus $4.35
- 01/17/23
- Progress Software sees Q1 EPS $1.04 - $1.08, consensus $1.05
- 01/17/23
- Progress Software reports Q4 EPS $1.12, consensus $1.09
- 09/27/22
- Progress Software raises FY22 EPS view to $4.08-$4.12 from $4.05-$4.11
- 01/17/23
- Nicolet Bankshares reports Q4 non-GAAP EPS $1.86, consensus $2.00
- 10/25/22
- Nicolet Bankshares reports Q3 adjusted EPS $1.74, consensus $1.82
- 07/19/22
- Nicolet Bankshares reports Q2 EPS $1.73, consensus $1.69
- 11/03/22
- Moderna reports Q3 EPS $2.53, consensus $3.29
- 11/02/22
- Notable companies reporting before tomorrow's open
- 08/03/22
- Moderna reports Q2 GAAP EPS $5.24, consensus $4.55
- 01/17/23
- Interactive Brokers reports Q4 adjusted EPS $1.30, consensus $1.17
- 10/18/22
- Interactive Brokers reports Q3 adjusted EPS $1.08, consensus 96c
- 07/19/22
- Interactive Brokers reports Q2 EPS 84c, consensus 91c
- 01/17/23
- Hancock Whitney reports Q4 EPS $1.65, consensus $1.65
- 10/18/22
- Hancock Whitney reports Q3 EPS $1.55, consensus $1.54
- 07/19/22
- Hancock Whitney reports Q2 EPS $1.38, consensus $1.37
- 11/14/22
- Arcimoto reports Q3 EPS (38c), consensus (30c)
- 08/15/22
- Arcimoto reports Q2 EPS (44c), consensus (30c)
FULC Fulcrum Therapeutics - 11/08/22
- Fulcrum Therapeutics reports Q3 EPS (51c), consensus (61c)
- 08/11/22
- Fulcrum Therapeutics reports Q2 EPS (83c), consensus (66c)
- 01/17/23
- Big 5 Sporting reports FY22 revenue $995.5M vs. $1.16B last year
- 01/17/23
- Big 5 Sporting sees Q4 EPS 7c-8c vs previous view 8c-20c
- 11/01/22
- Big 5 Sporting expects Q4 EPS 8c-20c, one est. 29c
- 11/01/22
- Big 5 Sporting reports Q3 EPS 29c vs. $1.07 last year
|
Hot Stocks
|
AMMO, the owner of… AMMO, the owner of GunBroker.com, the largest online marketplace serving the firearms and shooting sports industries, and a leading vertically integrated producer of high-performance ammunition and components, announced it has appointed Randy Luth, a firearm industry veteran, to serve on the Company's Board of Directors. Mr. Luth previously served on AMMO's board from 2017 to 2021. ShowHide Related Items >><< - 01/03/23
- AMMO, GunBroker.com to exhibit at 2023 SHOT Show
- 12/15/22
- AMMO appoints Smith as Chief Operating Officer, President
- 11/07/22
- AMMO reaches settlement agreement with The Urvan Group
- 10/26/22
- AMMO to export 2.5M rounds of .50BMG
- 11/15/22 Lake Street
- AMMO price target lowered to $5 from $9 at Lake Street
- 11/15/22 Roth MKM
- AMMO downgraded to Neutral from Buy at Roth Capital
- 08/16/22 Lake Street
- AMMO price target lowered to $9 from $12 at Lake Street
- 06/30/22 EF Hutton
- AMMO shares should be bought 'aggressively,' says EF Hutton
- 11/14/22
- AMMO lowers FY23 revenue view to $220M-$240M, consensus $295.12M
- 11/14/22
- AMMO reports Q2 adjusted EPS 5c, consensus 4c
- 08/15/22
- AMMO reports Q1 EPS 9c vs. 13c last year
- 09/01/22
- Bear Cave's Dorsey sees 'problems' at AMMO
- 11/15/22
- What You Missed On Wall Street This Morning
- 11/14/22
- Fly Intel: After-Hours Movers
- 10/06/22
- What You Missed On Wall Street This Morning
- 09/01/22
- What You Missed On Wall Street On Thursday
- 08/18/22
- Largest borrow rate increases among liquid names
- 08/15/22
- AMMO options imply 11.7% move in share price post-earnings
|
Hot Stocks
|
Wrap Technologies… Wrap Technologies announced the full deployment of BolaWrap 150 remote restraint devices covering multiple law enforcement agencies in Montgomery County, Texas. The sale was funded through a grant awarded by the Court of Commissioners of Montgomery County. The agencies that will be fully equipped are the Montgomery County Sheriff's Office, all five Montgomery County Constable Offices, and the Montgomery County Fire Marshal's Office."This county-wide large-scale deployment of BolaWrap 150 demonstrates a strong commitment from Montgomery County, Texas to keep officers and communities safe," said Kevin Mullins, President of WRAP. "Law enforcement agencies worldwide, including the hardworking men and women of Montgomery County are recognizing the value of our innovative, de-escalation technologies. We would like to thank the Court of Commissioners of Montgomery County for their support of WRAP and our mission to save lives." BolaWrap 150 enables police officers to take individuals safely into custody without having to use force or pain, keeping subjects and officers safer. Unlike other restraint devices currently available, BolaWrap 150 can subdue a subject from a distance without using pain compliance. ShowHide Related Items >><< - 11/30/22
- Wrap Technologies announces Technology Acquisition Agreement with Lumento
- 10/13/22
- Wrap Technologies launches new module for law enforcement training platform
- 09/14/22
- Wrap announces new footage of successful deployment of BolaWrap device
- 08/24/22
- Wrap Technologies announces extension of LAPD BolaWrap Pilot Program
- 08/12/22 Ladenburg
- Wrap Technologies downgraded to Neutral from Buy at Ladenburg
- 03/11/22 Ladenburg
- Wrap Technologies price target lowered to $5.25 from $6.25 at Ladenburg
- 01/25/22 Maxim
- Wrap Technologies downgraded to Hold at Maxim on management departures
- 01/25/22 Maxim
- Wrap Technologies downgraded to Hold from Buy at Maxim
- 08/10/22
- Wrap Technologies reports Q2 EPS (12c), consensus (13c)
|